Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 215,453,219 papers from all fields of science
Search
Sign In
Create Free Account
Aqueous Flare
Known as:
Aqueous Flares
, Flare, Aqueous
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Aqueous Humor
Aqueous Humor Disorders
Secondary iridocyclitis, noninfectious
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits
Momoko Nakamura-Shibasaki
,
Miftahul Akhyar Latief
,
Ji-ae Ko
,
Kunihiko Funaishi
,
Yoshiaki Kiuchi
Japanese Journal of Ophthalmology
2016
Corpus ID: 264019026
PurposeTo evaluate the effects of signals through adrenergic receptors on the changes in the aqueous flare and intraocular…
Expand
2016
2016
LABORATORY INVESTIGATION : Effects of topical adrenergic agents on prostaglandin E2-induced aqueous flare and intraocular pressure elevation in pigmented rabbits
Momoko Nakamura-Shibasaki
,
Miftahul Akhyar Latief
,
Ji-Ae Ko
2016
Corpus ID: 1787599
1996
1996
Nitric oxide synthase inhibitors exert differential time-dependent effects on LPS-induced uveitis.
J. Allen
,
M. Mcgahan
,
J. Ferrell
,
K. Adler
,
L. Fleisher
Experimental Eye Research
1996
Corpus ID: 35184745
Nitric oxide (NO) is a highly reactive radical which plays an integral role in physiological and pathophysiological processes. NO…
Expand
1994
1994
[The effects of calcium antagonists on prostaglandin E2 reaction in rabbit eyes].
Y. Kaji
,
S. Hiraki
,
H. Hirata
Nippon Ganka Gakkai zasshi
1994
Corpus ID: 45206184
We determined the effects of calcium antagonists (CAs) on prostaglandin E2 (PGE2) induced responses in the anterior ocular…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE